| [1] |
Beneke S. 2012. Regulation of chromatin structure by poly(ADP-ribosyl)ation. |
| [2] |
Barkauskaite E, Jankevicius G, Ahel I. 2015. Structures and mechanisms of enzymes employed in the synthesis and degradation of PARP-dependent protein ADP-ribosylation. |
| [3] |
Ray Chaudhuri A, Nussenzweig A. 2017. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. |
| [4] |
Westcott NP, Fernandez JP, Molina H, Hang HC. 2017. Chemical proteomics reveals ADP-ribosylation of small GTPases during oxidative stress. |
| [5] |
O'Sullivan J, Tedim Ferreira M, Gagné JP, Sharma AK, Hendzel MJ, et al. 2019. Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation. |
| [6] |
Mariotti L, Pollock K, Guettler S. 2017. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding. |
| [7] |
Reber JM, Mangerich A. 2021. Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly(ADP-ribose). |
| [8] |
Lüscher B, Bütepage M, Eckei L, Krieg S, Verheugd P, et al. 2018. ADP-ribosylation, a multifaceted posttranslational modification involved in the control of cell physiology in health and disease. |
| [9] |
Hou WH, Chen SH, Yu X. 2019. Poly-ADP ribosylation in DNA damage response and cancer therapy. |
| [10] |
Martí JM, Fernández-Cortés M, Serrano-Sáenz S, Zamudio-Martinez E, Delgado-Bellido D, et al. 2020. The multifactorial role of PARP-1 in tumor microenvironment. |
| [11] |
Li P, Wu D, Yu X. 2025. Targeting dePARylation in cancer therapy. |
| [12] |
Suskiewicz MJ, Prokhorova E, Rack JGM, Ahel I. 2023. ADP-ribosylation from molecular mechanisms to therapeutic implications. |
| [13] |
Huang D, Wang J, Chen L, Jiang W, Inuzuka H, et al. 2025. Targeting the PARylation-dependent ubiquitination signaling pathway for cancer therapies. |
| [14] |
Kamaletdinova T, Fanaei-Kahrani Z, Wang ZQ. 2019. The enigmatic function of PARP1: from parylation activity to PAR readers. |
| [15] |
Huang D, Kraus WL. 2022. The expanding universe of PARP1-mediated molecular and therapeutic mechanisms. |
| [16] |
Huang HS, Chen L, Chi JX, Lai SY, Pi J, et al. 2025. Stress granules and cell death: crosstalk and potential therapeutic strategies in infectious diseases. |
| [17] |
Fahrer J, Kranaster R, Altmeyer M, Marx A, Bürkle A. 2007. Quantitative analysis of the binding affinity of poly(ADP-ribose) to specific binding proteins as a function of chain length. |
| [18] |
Nosella ML, Kim TH, Huang SK, Harkness RW, Goncalves M, et al. 2024. Poly (ADP-ribosyl) ation enhances nucleosome dynamics and organizes DNA damage repair components within biomolecular condensates. |
| [19] |
Fu H, Liu R, Jia Z, Li R, Zhu F, et al. 2022. Poly(ADP-ribosylation) of P-TEFb by PARP1 disrupts phase separation to inhibit global transcription after DNA damage. |
| [20] |
Dasovich M, Leung AKL. 2023. PARPs and ADP-ribosylation: deciphering the complexity with molecular tools. |
| [21] |
Matsumoto K, Matsumoto Y, Jun W. 2025. PARylation-mediated post-transcriptional modifications in cancer immunity and immunotherapy. |
| [22] |
Leung AKL. 2020. Poly(ADP-ribose): a dynamic trigger for biomolecular condensate formation. |
| [23] |
Liu H, Pillai M, Leung AKL. 2025. PARPs and ADP-ribosylation-mediated biomolecular condensates: determinants, dynamics, and disease implications. |
| [24] |
Cohen MS. 2021. Catching mono- and poly-ADP-ribose readers with synthetic ADP-ribose baits. |
| [25] |
Daniels CM, Ong SE, Leung AKL. 2015. The promise of proteomics for the study of ADP-ribosylation. |
| [26] |
Kliza KW, Liu Q, Roosenboom LWM, Jansen PWTC, Filippov DV, et al. 2021. Reading ADP-ribosylation signaling using chemical biology and interaction proteomics. |
| [27] |
Dasovich M, Beckett MQ, Bailey S, Ong SE, Greenberg MM, et al. 2021. Identifying poly(ADP-ribose)-binding proteins with photoaffinity-based proteomics. |
| [28] |
Lam AT, Zhang XN, Courouble VV, Strutzenberg TS, Pei H, et al. 2021. A bifunctional NAD+ for profiling poly-ADP-ribosylation-dependent interacting proteins. |
| [29] |
Kalesh K, Lukauskas S, Borg AJ, Snijders AP, Ayyappan V, et al. 2019. An integrated chemical proteomics approach for quantitative profiling of intracellular ADP-ribosylation. |
| [30] |
Jiang H, Kim JH, Frizzell KM, Kraus WL, Lin H. 2010. Clickable NAD analogues for labeling substrate proteins of poly (ADP-ribose) polymerases. |
| [31] |
Buntz A, Wallrodt S, Gwosch E, Schmalz M, Beneke S, et al. 2016. Real-time cellular imaging of protein poly (ADP-ribos) ylation. |
| [32] |
Wallrodt S, Buntz A, Wang Y, Zumbusch A, Marx A. 2016. Bioorthogonally functionalized NAD+ analogues for in-cell visualization of poly(ADP-ribose) formation. |
| [33] |
Kasprzyk R, Rieth S, Heid P, Stengel F, Marx A. 2024. Cell-permeable nicotinamide adenine dinucleotides for exploration of cellular protein ADP-ribosylation. |
| [34] |
Carter-O'Connell I, Jin H, Morgan RK, David LL, Cohen MS. 2014. Engineering the substrate specificity of ADP-ribosyltransferases for identifying direct protein targets. |
| [35] |
Gibson BA, Zhang Y, Jiang H, Hussey KM, Shrimp JH, et al. 2016. Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation. |
| [36] |
Zhang XN, Cheng Q, Chen J, Lam AT, Lu Y, et al. 2019. A ribose-functionalized NAD+ with unexpected high activity and selectivity for protein poly-ADP-ribosylation. |
| [37] |
Langelier MF, Zandarashvili L, Aguiar PM, Black BE, Pascal JM. 2018. NAD+ analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains. |
| [38] |
Zhang XN, Lam AT, Cheng Q, Courouble VV, Strutzenberg TS, et al. 2022. Discovery of an NAD+ analogue with enhanced specificity for PARP1. |
| [39] |
Wang Y, Rösner D, Grzywa M, Marx A. 2014. Chain-terminating and clickable NAD+ analogues for labeling the target proteins of ADP-ribosyltransferases. |
| [40] |
Löffler T, Krüger A, Zirak P, Winterhalder MJ, Müller AL, et al. 2023. Influence of chain length and branching on poly(ADP-ribose) – protein interactions. |
| [41] |
Hegedűs C, Virág L. 2014. Inputs and outputs of poly(ADP-ribosyl) ation: Relevance to oxidative stress. |
| [42] |
Jungmichel S, Rosenthal F, Altmeyer M, Lukas J, Hottiger MO, et al. 2013. Proteome-wide identification of poly(ADP-ribosyl) ation targets in different genotoxic stress responses. |
| [43] |
Rodríguez-Vargas JM, Oliver-Pozo FJ, Dantzer F. 2019. PARP1 and poly (ADP-ribosyl) ation signaling during autophagy in response to nutrient deprivation. |
| [44] |
De Chiara G, Marcocci ME, Sgarbanti R, Civitelli L, Ripoli C, et al. 2012. Infectious agents and neurodegeneration. |
| [45] |
Wongchitrat P, Chanmee T, Govitrapong P. 2024. Molecular mechanisms associated with neurodegeneration of neurotropic viral infection. |
| [46] |
Lu B, Guo S. 2020. Mechanisms linking mitochondrial dysfunction and proteostasis failure. |
| [47] |
Artero-Castro A, Perez-Alea M, Feliciano A, Leal JA, Genestar M, et al. 2015. Disruption of the ribosomal P complex leads to stress-induced autophagy. |
| [48] |
Yang W, Wang H, Li Z, Zhang L, Liu J, et al. 2024. RPLP1 restricts HIV-1 transcription by disrupting C/EBPβ binding to the LTR. |
| [49] |
Ryu KW, Kim DS, Kraus WL. 2015. New facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases. |
| [50] |
Lu H, Yang M, Zhou Q. 2023. Reprogramming transcription after DNA damage: recognition, response, repair, and restart. |
| [51] |
Reichmann D, Voth W, Jakob U. 2018. Maintaining a healthy proteome during oxidative stress. |
| [52] |
Genuth NR, Dillin A. 2025. Translational regulation in stress biology. |